The price of generic clozapine 100 mg can vary based on the pharmacy, location, and insurance coverage. In the United States, a prescription for 30 tablets of 100 mg generic clozapine can range from approximately $10 to $30 with a discount card [1]. Without insurance, the cost can be significantly higher.
How much does clozapine 100 mg cost without insurance?
Without insurance, a 30-day supply of 100 mg generic clozapine can cost between $50 and $150 or more [1]. Prices can fluctuate between different pharmacies.
Where can I find discounts for clozapine 100 mg?
Discount cards and coupons are available from various sources, including online prescription discount providers and patient assistance programs. These can reduce the out-of-pocket cost for generic clozapine [1]. Some pharmacies also offer their own discount programs.
What is clozapine used for?
Clozapine is an atypical antipsychotic medication primarily used to treat schizophrenia in individuals who have not responded to other treatments. It is also used to reduce the risk of suicidal behavior in patients with schizophrenia or schizoaffective disorder [2].
What are the side effects of clozapine?
Common side effects of clozapine include drowsiness, dizziness, weight gain, and increased salivation. More serious side effects can include agranulocytosis (a severe drop in white blood cells), seizures, myocarditis (inflammation of the heart muscle), and neuroleptic malignant syndrome [2]. Due to these risks, patients on clozapine require regular blood monitoring.
When does the patent for clozapine expire?
Clozapine, originally marketed as Clozaril, has been available as a generic for many years. The original patents for the active ingredient clozapine have long expired, allowing for the production and sale of generic versions [3].
What are clozapine alternatives?
Other antipsychotic medications are available for schizophrenia and related disorders, including risperidone, olanzapine, quetiapine, and aripiprazole. However, clozapine is often considered for patients who have not responded adequately to these other treatments [2].
Sources:
1. DrugPatentWatch.com
2. National Institute of Mental Health
3. U.S. Food and Drug Administration